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Abstract
Anaplastic Lymphoma Kinase (ALK) was initially discovered as an oncogene in human lymphoma and other cancers,
including neuroblastoma. However, little is known about the physiological function of ALK. We identified the alk ortholog in
zebrafish (Danio rerio) and found that it is highly expressed in the developing central nervous system (CNS). Heat-shock
inducible transgenic zebrafish lines were generated to over-express alk during early neurogenesis. Its ectopic expression
resulted in activation of the MEK/ERK pathway, increased cell proliferation, and aberrant neurogenesis leading to mis-
positioning of differentiated neurons. Thus, overexpressed alk is capable of promoting cell proliferation in the nervous
system, similar to the situation in ALK-related cancers. Next, we used Morpholino mediated gene knock-down and a
pharmacological inhibitor to interfere with expression and function of endogenous Alk. Alk inhibition did not affect neuron
progenitor formation but severely compromised neuronal differentiation and neuron survival in the CNS. These data
indicate that tightly controlled alk expression is critical for the balance between neural progenitor proliferation,
differentiation and survival during embryonic neurogenesis.
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Introduction
Anaplastic Lymphoma Kinase (ALK) was initially discovered as an
oncogene in human anaplastic large cell lymphomas (ALCL), a
subset of T-cell lymphomas [1,2,3]. Genetic dissection revealed an
hybrid gene (NPM-ALK, also known as p80) at the t(2;5)(p23;q35)
chromosomal translocation breakpoint, comprising a fusion of a
nucleolar protein gene nucleophosmin (NPM) and a part of a gene
coding for ALK, a novel tyrosine kinase. Moreover, another fusion
of alk with the gene encoding echinoderm microtubule-associated protein-
like4, encoding EML4-ALK hybrid protein, was identified in a
subset of non-small-cell lung cancers (NSCLCs) [4]. To date,
several more ALK hybrid proteins have been identified in various
cancer types, such as TRK-fused gene (TFG)-ALK, tropomyosin 3
(TPM3)-ALK, tropomyosin 4 (TPM4)-ALK, clathrin heavy chain-
like 1 (CLTCL1)-ALK, and moesin (MSN)-ALK [5]. In most, if
not all, of these hybrid proteins the distal portion of ALK
containing the tyrosine kinase domain is fused with proximal parts
of the diverse proteins having oligomerization domains. Conse-
quently, the hybrid proteins undergo spontaneous dimerization,
leading to autophosphorylation and ultimately constitutive enzy-
matic activation of the ALK tyrosine kinase domain.
Overexpression of ALK is often observed in human neural
tumors, primarily neuroblastoma [6]. Neuroblastomas are embry-
onic tumors of the peripheral sympathetic nervous system derived
from neural crest tissues. It is one of the most frequent pediatric
solid tumors, accounting for about 15% of childhood cancer
mortality [7]. A clear correlation of ALK deregulation with
neuroblastoma development has been established [8,9,10,11], and
at least ten ALKmutations, all found in the tyrosine kinase domain,
were identified in the neuroblastoma samples. Among these,
R1275Q, F1174L and F1245L/V/C occur most frequently
[8,11]. Increased copy numbers and gene amplifications of the
ALK locus is also often detected in neuroblastoma patients [8,10].
These germ line mutations in ALK explain most of the inheritable
neuroblastomas, but activating mutations can also be somatically
acquired. These mutations lead to constitutive autophosphory-
lation of mutated ALK, which displays increased kinase activity
and excess phosphorylation on downstream targets such as Akt,
STAT3 and ERK1/2. Mutated ALK from neuroblastoma samples
is capable of transforming interleukin-3-dependent haematopoietic
Ba/F3 cells into cytokine-independent growth [9], as well as
NIH3T3 fibroblasts into colony and tumors in nude mice [8].
Knock-down of ALK by siRNA [8,11], or ALK inhibition by small
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molecules PF-2341066/Crizotinib [10] and TAE684 [9] leads to
suppressed cell growth, with decreased proliferation and increased
apoptosis in neuroblastoma cells harboring mutated or amplified
ALK. Together, these studies in neuroblastomas suggest that in a
normal cellular context, appropriate ALK expression and activity
levels need to be maintained for cell proliferation and survival.
While a pathogenic role for ALK has been demonstrated for
many human cancers, little is known about the physiological
function of Alk during development [12,13,14,15]. Expression of
ALK has been reported in murine neural tissues [13,14,16] but its
function, especially in the CNS, remains elusive. A recent report in
chicken showed that Alk controls proliferation of sympathetic
neurons in the peripheral nervous system (PNS) (Reiff et al., 2011).
In zebrafish (Danio rerio), a closely related co-ortholog of Alk,
leukocyte tyrosine kinase (ltk) encodes a 1530 amino acids (aa) long
protein [17]. ltk is expressed in neural crest cells (NCCs) and
iridophores, a pigment cell type widespread in anamniote
vertebrates. ltk is mutated in zebrafish shady mutants, which are
characterized by the complete lack of iridophores and the loss of a
subset of NCCs by apoptosis. Further analysis revealed that
zebrafish ltk controls fate specification in a distinct subset of NCCs
derived from the multipotent premigratory NCCs [17].
In the present study, we identified the full length zebrafish alk
sequence and show that alk is expressed in the developing zebrafish
CNS, that its over-expression results in increased proliferation of
neural progenitors and that it is required for neuronal differen-
tiation and survival. This is the first study that investigates Alk
function is zebrafish and shows a critical role for Alk in the
embryonic CNS.
Materials and Methods
Cloning of full-length zebrafish alk
The 59UTR and N-terminal zebrafish alk sequences were
obtained by 59RACE (Rapid Amplification of cDNA Ends) using a
kit from Invitrogen. The full length alk coding sequence was then
PCR amplified with Phusion polymerase (Finnzymes), primers
ALKatgXhoI (59- CCGCTCGAGCCACCATGTGTGA-
TAACGCAGCAGAG -39) and ALKdownXbaI (59- TGCTCTA-
GATTACAGCACAGTGGCGTTGT -39), and cloned into
pCS2+ (for capped mRNA preparation) or alk:HSE:cfp (for
generation of transgnic fish, see below) using XhoI and XbaI sites
present in these vectors.
Generation and maintenance of transgenic fish
All animal experiments were performed in accordance with
approved IACUC protocols of the National University of
Singapore (protocol numbers 075/07; 082/10; BR19/10). Zebra-
fish inbred AB wild-type strains were crossed to obtain embryos
that were raised in 30% Danieau’s solution at 28uC and staged as
described previously [18]. For generation of transgenic fish, a
alk:HSE:cfp construct was generated that contains the full-length
zebrafish alk and cfp under control of a bidirectional heat-shock
promoter in addition to flanking I-SceI sites [19,20]. HSE:cfp was
used as control. Plasmid DNA and I-SceI meganuclease (New
England Biolabs) were co-injected into AB wild-type embryos at
the one-cell stage as described [21]. On the next day, injected
embryos were heat shocked for 1 hr at 39C. Embryos with strong
CFP expression were raised to adulthood and crossed to WT AB
fish. For screening and maintaining these lines, embryos were
heat-shocked after 24 hpf to prevent early embryonic defects
caused by alk overexpression. F2 or F3 embryos of two
independent alk overexpressing lines (alk:HSE:cfp1 and al-
k:HSE:cfp2) and the HSE:cfp control line were used in the
experiments described below.
Morpholino and RNA microinjection
The following Morpholino oligonucleotides (MO; from Gene-
Tools, Philomath USA) were used: alk-ATG MO, 59-
TCCTCTGCTGCGTTATCACACATTC-39; alk-ATG-mis-
match control MO, 59-TCgTCTcCTGCcTTATgACAgATTC-
39 (base substitutions indicated by small letters); splice-site MOs:
alk-E3I3 MO, 59-CATTTATGCAGAGCACCTGGTGATG-39,
and alk-I3E4 MO, 59-CAAGGCCCCTGCCAGACAGAAT-
GAT-39; standard control MO, 59-CCTCTTACCTCAGTTA-
CAATTTATA-39; p53 MO, 59-GCGCCATTGCTTTGCAA-
GAATTG-39. All MOs were injected at 2 mg/ml, except for MO
efficiency tests (5 mg/ml) and for the p53 MO (8 mg/ml).
Capped mRNAs were synthesized in vitro using the mMES-
SAGE mMACHINE SP6 Kit (Ambion). NPM-ALK mRNA was
injected at 50 ng/ml. alkATG-egfp mRNA was injected at 50 ng/
ml. To test the translation blocking efficiency of the alk ATG-MO,
a target construct alkATG-egfp was generated that contains the alk
59UTR and the ATG-MO target site, in addition to a 6 bp XhoI
linker, in-frame with the egfp coding sequence.
RNA in situ hybridization, immunostaining and Western
blotting
Whole mount RNA in situ hybridization and immunostaining
were performed as described earlier [22]. An antisense riboprobe
comprising the alk sequence from nt 6–885 was used to detect alk
expression, and a sense probe covering the same sequence was
used as control. The following primary antibodies were used: anti-
phospho-Histone 3 (anti-pH 3; Millipore); anti-HuC/HuD (anti-
HuC/D; Molecular Probes); anti-ERK1/2 (Santa Cruz); and anti-
phospho-ERK1/2 (anti-pERK; Cell Signaling). For detection,
either the VECTASTAIN Elite ABC Kit (Vector Labs) for
diamino benzidine (DAB; Sigma) staining was used, or Alexa
Fluor-488/568 coupled secondary antibodies (Invitrogen) for
fluorescence detection. TUNEL assays were performed using the
ApopTag Peroxidase In Situ Apoptosis Detection Kit (Millipore)
or with an anti-DIG primary antibody (Roche) for fluorescence
detection. For 5-bromo-2-deoxyuridine (BrdU) labelling of cells in
S-phase, embryos were incubated in 10 mM BrdU (Sigma) for
15 min on ice before fixation, followed by detection with an anti-
BrdU primary antibody (DSHB, University of Iowa) as described
previously [23]. For Western analysis, zebrafish embryos were
deyolked and proteins extracted as previously described [24].
Western blotting was performed with anti-ERK and anti-pERK
antibodies using standard protocols.
Alk inhibitor treatment
Dechorionated embryos were incubated with the pharmaco-
logical Alk inhibitor CEP-26939 [Teva Pharmaceuticals, also
known as cmpd 13; 25] at 40 mM with 1% DMSO in Danieau’s
solution. 1% DMSO in fish medium was used as control. Embryos
were treated from 24 hpf to 60 hpf, with changes of medium every
12 hours, and fixed at 60 hpf for further processing.
Microscopy, cell counting and statistical analysis
Confocal images were taken with a Zeiss LSM 510 Meta laser
scanning microscope. All other images were taken with a Nikon
SMZ1000 or a Nikon ECLIPSE 90i microscope. pH 3 positive
cells were counted in confocal projections of 20 continuous optical
sections representing a 50 mm thick area within rhombomeres r4
to r6. For cell counting, BODIPY-Texas-Red (Molecular Probes,
Alk in Zebrafish Neurogenesis
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Invitrogen) was used to counterstain cell membranes of HuC/D
positive neurons. Embryos were stained in 20 mM BODIPY-TR
for 1 h prior to imaging [26,27]. Statistical analysis was done with
GraphPad Prism 5. Unpaired two-tailed Student’s t-test was used
in comparisons between treated and control groups, with p,0.05
indicating statistical significance. Bar graphs were plotted with
GraphPad Prism 5, showing means with standard error means
(SEM) as error bars.
Results
Identification of full-length zebrafish alk
A partial zebrafish anaplastic lymphoma kinase (alk) sequence
was available in the NCBI database (GenBank: XM_686872.2). It
is located on chromosome 17 (Ensembl: ENSDARG00000095833)
and comprises a putative 4164 base pairs (bp) transcript encoding
1387 amino acids (aa). We used 59RACE to identify a 216 bp 59
UTR that contains several STOP codons in all three reading
frames, and the predicted translation start site of zebrafish alk. The
full-length zebrafish alk coding region contains 4167 bp encoding
a 1388 aa protein. The zebrafish Alk tyrosine kinase (TK) domain
(aa 795–1062) has 89.6% aa identity to that of human ALK (aa
1116–1383; GenBank: NM_004304.4). Key tyrosine residues are
present in zebrafish Alk (Y957, Y961 and Y962) that correspond to
the human ALK kinase domain activation loop, a YXXXYY
motif. Notably, this motif presents as YRASYY in all vertebrate
Alk proteins, and slightly modified as YRSDYY in the fruit fly
[28]. Moreover, three other residues in the TK domain: F1174,
F1245 and R1275 that are most frequently affected by gain-of-
function mutations in human neuroblastoma [8,11] are also
conserved in zebrafish Alk (F853, F924 and R954, respectively).
Together, these data suggest a critical role for the highly conserved
Alk residues in zebrafish.
Zebrafish alk expression during embryonic neurogenesis
We examined Alk mRNA transcript expression by RT-PCR at
developmental stages from 6 hours post fertilization (hpf) to
72 hpf. Alk transcripts are first detected at 12 hpf, and expression
levels continuously increased with the most profound increase at
48 hpf (Fig. 1A). The appearance of alk expression shortly after
gastrulation corresponds to the initiation of segmentation and
neurulation (10 hpf; [18]. Neurogenesis in the zebrafish hindbrain
peaks between 24 hpf and 48 hpf, when the neuron to progenitor
ratio changes most significantly [29]. The increase of alk mRNA
levels from 12 hpf to 48 hpf therefore coincides with neurogenesis
in zebrafish. In adult tissues, alk is highly expressed in brain, with
much lower expression in heart, caudal fin, as well as testis, and
none detectable in liver (Fig. 1B). Abundant expression of alk in
adult brain suggests that it may function in adult neurogenesis and
neural regeneration, which is prominent in zebrafish [30].
To analyze the spatial control of alk expression, whole mount in
situ hybridization was performed with two antisense alk riboprobes
representing either the alk N- (nt 6–885) or C-terminus (nt 3393–
4071) in embryos at 24, 48 and 72 hpf. Both probes showed
identical patterns (Fig. 1C–K; Fig. S1; and data not shown).
Sense probes were used as negative control and showed no
staining (Fig. S1). As early as 24 hpf, alk transcripts were broadly
expressed in the developing central nervous system (CNS)
including the spinal cord, with elevated levels in the brain
(Fig. 1C). At 48 hpf, strong expression was found in the mid- and
hindbrain (Fig. 1H), which remained high at 72 hpf (Fig. S1H,I).
Transverse sections of embryos at 24 (Fig. 1D–G) and 48 hpf
(Fig. 1I–K) at different brain levels showed that alk is expressed in
the entire brain, with higher expression in ventral than dorsal
regions of the early forebrain (Fig. 1D) and midbrain (Fig. 1E). In
the hindbrain, expression levels were higher in regions where
differentiated neurons locate rather than in regions with newborn
progenitors (Fig. 1F,K), especially at 48 hpf [29].
Increased neural proliferation and aberrant neurogenesis
in embryos ectopically expressing alk
We generated transgenic alk:HSE:cfp zebrafish lines that
simultaneously co-express CFP and wild-type Alk under control
of a bi-directional heat-shock promoter (Fig. S2)[19]. A control
line with only the cfp sequence was also established (Fig. S2A).
Embryos showing no CFP signal after heat shock (transgenic
negative siblings (Sib); arrows in Fig. S2) were used as negative
controls for comparison. In situ hybridization at different time
points after heat shock at 24 hpf showed elevated levels of alk
mRNA, detectable as soon as 1 hour post heat shock (hph; Fig.
S3A), degraded over time (Fig. S3B), and eventually returned to
the baseline alk concentration at 22 hph (Fig. S3C). A second heat
shock performed at 48 hpf reactivated the transgene (Fig. S3D).
CFP negative embryos showed no additional alk RNA (arrows in
Fig. S3), confirming that they were transgenic negative siblings.
Notably, after a 1.5 hour heat shock at 39.5uC at 10.5 hpf, all
transgenic alk expressing embryos in both lines showed marked
morphological malformations of the brain (Fig. S2D,E), similar to
embryos injected with human NPM-ALK mRNA (data not shown).
In contrast, HSE:cfp control embryos showed no defects with the
same treatment (Fig. S2C), suggesting that the observed defects
are caused by overexpressed Alk.
Defects in embryos heat shocked at 10.5 hpf were investigated
at 24 hpf. For quantification of cell numbers in the experiments
outlined below, we analyzed the hindbrain between rhombomeres
r4 and r6, using the otic vesicles as landmarks in transverse
sections (Fig. 2). Importantly, similar findings were also observed
in other regions of the CNS where endogenous alk is expressed at
24 hpf (Fig. 1C; data not shown). In alk-overexpressing embryos
(Tg+), the 4th ventricle, a normally T-shaped opening in the
hindbrain (asterisks in Fig. 2A,B,D), was completely absent.
Instead, several small cavities were observed (arrows in Fig. 2E,G,
with high magnification in the inset E9). This suggested early
neural tube defects, since the 4th ventricle, like other brain
ventricles, is formed by proliferation and differentiation in the
early neuroepithelium [18]. Accordingly, proliferation is abundant
at this stage in the zebrafish hindbrain [29], and cell divisions
occur almost exclusively at the most apical ventricular surface
[29,31]. In control siblings, proliferating cells positive for phospho-
histone 3 (pH 3) were observed at the apical surface as expected
(Fig. 2A,B,D). In contrast, in all alk Tg+ embryos of the
alk:HSE:cfp1 line, pH 3 positive cells were localized in a completely
randomized manner (Fig. 2E–G). Similarly, differentiated post-
mitotic neurons are normally found in two clusters at each side of
the basal and lateral regions of the neural tube (arrowheads in
Fig. 2A,D; [29]. In alk Tg+ embryos, HuC/D positive cells
showed ectopic appearance at places, where they never occur in
controls (Fig. 2E–G), while the patterns of pH3+ and HuC/D+
cells was not affected in HSE:cfp Tg+ embryos (Fig. 2B). To rule
out possible positional effects of the inserted transgene, embryos of
the second line alk:HSE:cfp2 were examined and showed the same
results (Fig. S4B).
Counting pH 3 positive cells revealed that Tg+ embryos of both
alk:HSE:cfp1 and alk:HSE:cfp2 lines had an average of 44% and
53% more cells in M-phase compared to their Sib control groups,
respectively (36.50 6 2.16 vs. 25.30 6 0.84; 39.10 6 1.87 vs.
25.50 6 0.69) (Fig. 2C). Consistently, HSE:cfp control embryos
showed no significant difference from Sib embryos (25.40 6 0.54
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vs. 25.60 6 0.81). This indicates that overexpression of alk but not
CFP significantly elevates cell proliferation in the hindbrain. DNA
synthesis in cells at S-phase was analyzed by 5-bromo-2-
deoxyuridine (BrdU) labelling. In controls, BrdU cells occupy
intermediate domains between the ventricular surface division
zones and areas rich in postmitotic neurons, in a pattern
Figure 1. Expression of zebrafish alk. (A) RT-PCR of cDNA at different embryonic stages. gapdh is used as loading control. (B) RT-PCR of cDNA
from different adult tissues. beta-actin is used as loading control. (C) Lateral view of whole embryos at 24 hpf with dorsal up and anterior to the left.
Insert shows dorsal view of head region. (D–G) Transverse sections of embryos at 24 hpf, at forebrain (D), midbrain (E), rhombomere 2 (r2; F) and r5
(G) levels, corresponding to positions indicated by lines in (C). (H) Lateral view of whole embryo at 48 hpf with dorsal up and anterior to the left.
Insert shows dorsal view of head region. (I–K) Transverse sections of embryos at 48 hpf at forebrain (I), midbrain (J), and r5 (K), corresponding to
positions indicated by lines in (D). Scale bars: C,H, 200 mm; D–E,I–K, 100 mm.
doi:10.1371/journal.pone.0063757.g001
Figure 2. Overexpression of alk promotes cell proliferation and affects neurogenesis. (A,B) Confocal sections of HSE:cfp embryos. Sib (A)
and Tg+ (B) embryos show no difference in number and distribution of pH 3 and HuC/D positive cells. (C) Y-axis indicates numbers of pH 3 positive
cells counted in a 50 mm confocal stack of the hindbrain. Mean 6 SEM, n = 10 embryos in each group. Sib and Tg+ HSE:cfp embryos were not
significantly different (p = 0.84). Sib and Tg+ embryos of both alk:HSE:cfp lines were significantly different (***p,0.001). Unpaired two tailed t-test.
(D–G) Confocal sections of alk:HSE:cfp1 embryos. Sib (D) and Tg+ (E–G, from three different embryos) had different neural tube shapes. Dividing cells
(pH 3, green) and neurons (HuC/D, red) in Tg+ embryos (E–G) were mispositioned (arrowheads), with aberrant patterns. (E9) High magnification of
the boxed area in (E). Asterisk labels 4th ventricle. Arrows label small cavities found in the neural tube. (H,I) Confocal sections of alk:HSE:cfp1 embryos,
with BrdU labelled cells in S-phase. In Sib (H), BrdU positive cells occupy a region between dividing cells and neurons that exited the cell cycle, in a
pattern complementary to pH 3 and HuC/D in (A,B,D). In Tg+ (I), BrdU positive cells were randomly positioned. Smaller dimension of samples in (H,I)
might be due to HCl treatment in the experiment procedure. (J,K) Manual sections of embryos after in situ hybridization showed expanded ccnd1
expressions in Tg+ (K) in comparison to Sib embryos (J). Sib, transgenic negative siblings. Tg+, transgenic positive embryos. All images are sections
perpendicular to neural tube. Scale bars: 50 mm.
doi:10.1371/journal.pone.0063757.g002
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complementary to pH 3 and HuC/D positive cells (Fig. 2H). In
alk:HSE:cfp1 Tg+ embryos, S-phase cells were not restricted to
these positions but scattered throughout the hindbrain (Fig. 2I).
The total area with cells in S-phase was drastically expanded,
which made cell counting impossible. Interestingly, an increase of
cells in S-phase has also been reported in primary sympathetic
ganglia neuron cultures from embryonic chicken transfected with
human ALK gene [15].
To test whether the observed increased proliferation is
associated with upregulation of the cell cycle machinery, we
evaluated the expression of cyclin D (ccnd1), which is known to
promote proliferation by regulating cyclin dependent kinases
CDK4 and CDK6 [32]. cyclin D is overexpressed in many cancers
[32] including ALK positive neuroblastomas [5]. In non-transgenic
control embryos, ccnd1 expression was observed in two stripes of
the dorsal hindbrain (Fig. 2J). In contrast, alk:HSE:cfp1 Tg+
embryos exhibited an expansion of ccnd1 expression into other
regions of the hindbrain (Fig. 2K).
Overexpression of alk activates MAPK signaling in vivo
Activation of several signaling pathways has been reported in
human ALK-related cancers including MEK/ERK pathway
involved in cell proliferation [5]. In Drosophila, Alk functions
through ERK activation during visceral mesoderm development
[33,34,35,36]. To test whether the MEK/ERK pathway is
affected by the alk overexpression in zebrafish, we examined
phosphorylation of ERK1/2 (pERK) and expression of total ERK
levels using anti-pERK and anti-ERK antibodies, respectively
(Fig. 3; Fig. S4).
In 24 hpf WT embryos without heat shock, increased pERK
concentration could only be found in forebrain, mid-hindbrain
boundary, caudal-most hindbrain, spinal cord (Fig. 3A), as well as
the tail bud (image not shown). There were only few individual
pERK positive cells in the hindbrain (Fig. 3A). This distribution
was found in both Sib and Tg+ embryos of the HSE:cfp line, with
no additional pERK signals (Fig. 3B,C). In cross sections at the
level of r5, usually no pERK positive cells could be seen
(Fig. 3A9,B9,C9). This demonstrated that neither heat shock nor
overexpression of CFP activated ERK phosphorylation. In
contrast, in Tg+ embryos of alk:HSE:cfp lines, pERK was strongly
expressed across the entire CNS albeit in a mosaic pattern
(Fig. 3E,E9; Fig. S4D,D9), while the total ERK concentration
and distribution were similar to the control Sib line
(Fig 3F,F9,G,G9). Consistently, Western blot analysis showed
increased pERK levels but comparable ERK expression in Tg+
alk:HSE:cfp embryos at 22 hpf when compared to Sib controls
(Fig. 3H). The fusion protein NPM-ALK is a known highly
oncogenic form of ALK capable of activating MEK-ERK pathway
(Chiarle et al., 2008). Accordingly, embryos at 11 hpf injected with
human NPM-ALK mRNA showed increased pERK compared to
WT controls, with similar levels of total ERK protein (Fig. 3H).
Taken together, overexpression of alk causes up-regulation of
pERK while total ERK levels remain unchanged. Ubiquitous
MEK/ERK activation in the CNS upon alk overexpression is
consistent with the observed deregulation of cell proliferation and
aberrant neurogenesis.
Increased apoptosis but normal cell proliferation in the
hindbrain after alk knock-down
Morpholino oligonucleotides capable of blocking zebrafish alk
translation (ATG-MO) and a pair of splice blocking MOs (Spl-
MO) were designed to knock-down alk (Fig. S5A). As shown in
Figure 3. MAPK signaling is activated upon alk overexpression. (A,A9) phospho-ERK (pERK) immunostaining of a 24 hpf wild-type embryo
without heat shock. Endogenous MAPK activation is evident in the caudal most hindbrain and spinal cord, but low in other parts of the CNS.
(B,B9,C,C9) Both Sib (B,B9) and Tg+ embryos (C,C9) of the HSE:cfp control line were normal and no additional pERK was observed. (D,D9,E,E9) Ectopic
pERK (arrows) was evident in Tg+ (E,E9) of the alk:HSE:cfp1 line compared to Sib (D,D9). (F,F9,G,G9) Total ERK was ubiquitously distributed in both Sib
(F,F9) and Tg+ (G,G9) embryos of the alk:HSE:cfp1 line and showed no difference. (A9–G9) Transverse sections from embryos at r5 level as indicated by
black lines in (A–G). Sib, transgenic negative siblings. Tg+, transgenic positive embryos. ERK, total ERK1/2. pERK, phosphorylated-ERK1/2. Scale bars:
50 mm. (H)Western blot analysis showing more pERK protein in NPM-ALK mRNA injected embryos than in WT at 11 hpf. Each lane represents protein
content from five embryos of a 20–50 embryo pool. (I) Western blots showing increased pERK levels in Tg+ versus Sib embryos at 22 hpf in both
alk:HSE:cfp lines. Each lane contains proteins equivalent to five embryos of a 20–50 embryo pool. Only dissected anterior parts of embryos were used
to eliminate endogenous pERK originating from spinal cord and tail bud.
doi:10.1371/journal.pone.0063757.g003
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Fig. S5B, the alk ATG-MO suppressed GFP expression from an
alkATG-egfp target construct, while a corresponding alk ATGmis-
match-MO with 5 nt substitutions failed to block GFP expression
(Fig. S5C–F). Two splice MOs were designed to prevent splicing
of intron 3, which results in a 289 bp insertion leading to frame
shift with nine possible premature STOP codons (Fig. S5G). RT-
PCR with RNA from alk Spl-MO injected embryos at 24 hpf
showed a size increase as expected (Fig. S5H).
alk ATG-MO or Spl-MO were injected into zebrafish embryos
at the one- or two-cell stage, and apoptosis was examined at 22 hpf
using a transferase mediated dUTP nick end labeling (TUNEL)
assay. This showed increased apoptosis in the CNS (Fig. 4B,C,E;
Fig. S6C,F) when compared to uninjected WT (Fig. 4A; Fig.
S6A). Also, the size of the neural tube appeared smaller after alk
knock-down when compared to WT (Fig. 4A). Neither a standard
control MO nor the alk ATGmismatch-MO resulted in increased
apoptosis (Fig. S6B,E), suggesting that the increased apoptosis
was specific to alk deficiency. To further exclude MO off-target
effects due to p53 activation [37], a p53 MO [38] was co-injected
with alk MOs. This did not rescue the apoptosis defects caused by
alk ATG-MO or alk Spl-MO (Fig. S6D,G) indicating that the alk
MO knock-down effects are specific. Thus, alk depletion seems to
promote apoptosis in the CNS independent of the p53 pathway.
Interestingly, increased apoptosis was almost exclusively observed
in the CNS, where endogenous alk is expressed broadly during
early stages (24 hpf; Fig. 1C) thus further supporting the
specificity of the observed defects.
We also tested whether alk inhibition affected cell proliferation.
In embryos injected with either alk ATG-MO or Spl-MO, pH 3
positive cells were positioned normally (Fig. 4B,C). Counting of
pH 3 positive cells within the r4 - r6 hindbrain region (Fig. 4D)
revealed that neither alk ATG-MO (23.80 6 0.86) nor alk Spl-MO
(24.60 6 0.93) resulted in a significant difference when compared
to WT (25.00 6 0.84). In contrast, within the same samples,
counting of TUNEL positive cells (Fig. 4E) showed that both alk
ATG-MO (40.60 6 2.93) and alk Spl-MO (44.00 6 4.56) injected
embryos had significantly increased number of apoptotic cells as
compared to controls (5.406 1.44). These findings suggest that alk
deficiency may not affect dividing cells in M-phase. Since the
majority of cell divisions at this stage represent proliferative neural
progenitors, the increased apoptosis observed in alk morphants
most likely does not affect these progenitor cells, but rather other,
possibly more mature neuronal cell types.
Knock-down of alk impairs neuronal differentiation and
reduces neuron numbers in the hindbrain
As direct targets of Notch signaling, Hes genes (Hes1 and Hes5 in
mammals) are abundantly expressed in undifferentiated neural
progenitors and essential for maintaining stem cell identity [39].
We found no expression change of hairy-related 6 (her6), the
zebrafish Hes1 homolog [40], in alk morphants (Fig. 5B,B9,B0;
Fig. S7B) suggesting that proliferation of undifferentiated neural
progenitors is not affected by alk knock-down. In differentiating
neural cells, proneural gene expression is up-regulated as Notch-
Hes signaling is switched off. Combined expression of different
proneural genes restricts neuronal lineages, forces cell cycle exit,
initiates neuronal differentiation and promotes neuron survival
[41,42,43]. Expression of several zebrafish proneural genes was
Figure 4. Knock-down of alk does not affect proliferation but induces apoptosis in the hindbrain. (A–C) Confocal sections of 22 hpf
embryos after immunostaining with pH 3 (green) and TUNEL (red). Compared to WT (A), both alk ATG-MO injected (B) or alk Spl-MO injected (C)
embryos show pH 3 positive cells at normal positions, but more TUNEL positive cells are evident. Note that the size of neural tube in (B,C) is smaller
than in (A). (D) Y-axis indicates numbers of pH 3 positive cells in a 50 mm thick confocal stack of hindbrain. Numbers are not significantly different in
alk ATG-MO or alk Spl-MO from WT. (E) Y-axis indicates numbers of TUNEL positive cells in the same samples. Both alk ATG-MO and alk Spl-MO
numbers were different from that in WT with high significance (***p,0.001). Mean 6 SEM, n= 5 embryos in each group. Unpaired two tailed t-test.
Scale bars: 50 mm.
doi:10.1371/journal.pone.0063757.g004
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analyzed to study the effect of alk knock-down on neuronal
precursor differentiation. Neurogenin 1 (neurog1, neurod3) expression
was unchanged or only slightly reduced in alk morphants
(Fig. 5D,D9,D0; Fig. S7D). On the other hand, expression of
the zebrafish atonal ortholog, neurogenic differentiation 4 (neurod4, zath3)
was significantly reduced throughout the CNS, including the
hindbrain (Fig. 5F,F9,F0; Fig. S7F). The achaete-scute complex like
(ascl or ash) genes belong to another proneural gene family that can
act independently from atonal-related genes in vertebrates [44].
Expression of ascl1b was also reduced in alk morphants
(Fig. 5H,H9,H0; Fig. S7H). Moreover, delta A (dla), a Notch
ligand highly expressed in differentiating neurons, was also
reduced (Fig. 5J,J9,J0; Fig. S7J). Finally, glial fibrillary acidic protein
(gfap) expression was not changed in alkmorphants (Fig. 5L,L9,L0;
Fig. S7L). Of note, gfap is expressed in radial glia cells that overlap
with neural progenitors at this embryonic stage. All of the genes
mentioned above were expressed normally in alk ATGmismatch-
MO injected embryos (Fig. S7A,C,E,G,I,K). Taken together, we
observed a down-regulation of several proneural genes in alk
morphants. At the same time, progenitor marker expression was
unchanged and cell proliferation was not altered. This indicates
that progenitor cells do not require alk activity. Instead, we
propose that alk knock-down affects early neuronal precursors that
fail to differentiate and instead undergo programmed cell death.
MOs elicit their effects from earliest embryonic stages onward.
To achieve alk deficiency at later embryonic stages, a pharmaco-
logical ALK inhibitor, CEP-26939 was used. Both CEP-26939
and its closely related analog ALK inhibitor, CEP-28122, have
been reported to lead to growth inhibition in a variety of cultivated
human ALK-related cancer cell lines, including neuroblastoma,
through caspase 3/7 activation and apoptosis [25,45]. In our
experiment, zebrafish embryos were incubated in fish medium
containing CEP-26939, or DMSO alone as a negative control,
starting at 24 hpf. Embryos were fixed at 60 hpf and examined for
her6, neurog1, neurod4 and ascl1b expression, as well as apoptosis
(Fig. 6). Similar to the findings in Alkmorphants, TUNEL staining
revealed increased apoptosis in the CNS of the ALK inhibitor
treated embryos (Fig. 6A,B), which was also confirmed by
Acridine Orange staining in living embryos at 48 hpf (data not
shown). Consistent with the MO experiments, no difference in her6
expression was seen between inhibitor- and DMSO-treated groups
(Fig. 6C,D). Furthermore, only a weak reduction of neurog1
expression was observed with no major change in its overall
pattern (Fig. 6E,F). On the other hand, expression of neurod4 and
ascl1b was strongly reduced and almost completely absent in the
mid- and hindbrain in CEP-26939 treated embryos
(Fig. 6G,H,I,J). Significantly, in all regions where neurog1, neurod4
or ascl1b expression was reduced, the number of apoptotic cells
was strongly increased. Thus, this pharmacological ALK inhibitor
fully recapitulated the effects observed after MO-mediated ALK
depletion providing further evidence that ALK activity is required
for the differentiation and survival of early neural precursors in the
developing CNS.
The observed reduction of proneural gene expression suggested
compromised neuronal differentiation and survival. To test to
what degree alk deficiency affects the final steps of neurogenesis,
Figure 5. Knock-down of alk impairs neuronal differentiation. (A–L) In situ hybridization of neuronal marker genes with wild-type
(A,C,E,G,I,K), and alk Spl-MO injected embryos (B,D,F,H,J,L) at 22 hpf. Images in first row show dorsal views of head region with anterior to the left.
(A9–L9,A0 –L0) Transverse cross sections at the level of r2 (A9–L9) and r5 (A0 –L0) in WT embryos or alk Spl-MO injected morphants. (A,A9A0,B,B9B0)
her6 expression was unchanged in alk morphants compared to WT. (C,C9,C0,D,D9,D0) neurog1 expression was unchanged or only slightly reduced in
morphants. (E,E9,E0,F,F9,F0) neurod4 expression was strongly reduced in morphants in several regions including the hindbrain. (G,G9,G0,H,H9,H0)
Similarly, ascl1b expression in alk morphants was also significantly reduced. (I,I9,I0,J,J9,J0) dla expression in alk morphants was also reduced.
(K,K9,K0,L,L9,L0) Glia marker gfap expression was unchanged. Scale bars: 50 mm. Lines at r2 and r5 indicate levels of cross sections.
doi:10.1371/journal.pone.0063757.g005
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i.e. the formation of fully differentiated neurons, expression of the
pan-neuronal marker HuC/D [46,47] was analyzed. In the
hindbrain at 31 hpf, areas where postmitotic HuC/D+ neurons
are located were significantly reduced in size in alk morphants
(Fig. 7B,B9,C,C9) when compared to WT (Fig. 7A,A9) or
ATGmismatch-MO injected embryos (Fig. 7D,D9). In contrast,
proliferative ventricular and subventricular zones appeared
normal, when BODIPY-Texas Red was used to label cells
(Fig. 7E), an average of 92.25 6 2.94 HuC/D positive neurons
was counted per confocal single plane in controls (representing a
5 mm optical section). Cell numbers in the alk ATGmismatch-MO
injected group (85.14 6 2.71) were not significantly different from
WT. In contrast, numbers of HuC/D positive neurons were
reduced to 50.50 6 3.43 in alk ATG-MO injected embryos, and
46.36 6 2.64 in alk Spl-MO injected embryos. In conclusion, alk
ATG-MO or alk Spl-MO injected embryos show a significant
reduction in the number of differentiated neurons in the hindbrain
when compared to WT. Thus, alk is required for differentiation
and survival or early neural precursors in order to maintain the
correct number of fully differentiated hindbrain neurons at later
stages.
Discussion
This is the first study reporting structure and functional
characterization of zebrafish alk. It is also the first analysis of the
physiological role of Alk in the vertebrate central nervous system
(CNS). We show that zebrafish alk is expressed in the developing
CNS and is required for differentiation and survival of neural cells.
The full length zebrafish alk transcript encodes a deduced 1388
amino acids (aa) protein that matches a predicted partial zebrafish
alk sequence in the NCBI database (GenBank: XM_686872.2),
except an additional Glutamine (Q1280) in a Q(13) repeat located
at the C-terminal end, and a Serine (S309) to Alanine (A309)
replacement in a S(4) repeat located in its N-terminus. These
differences most likely reflect polymorphisms between different
zebrafish wild-type strains. Interestingly, the N-terminus of
zebrafish Alk (aa 1-708) shares only 25.3% aa identity with its
human counterpart (aa 1-1029) and seems to be significantly
shorter, while the TK domain shows 89.6% identity. Similarly,
chicken Alk (GenBank: XM_419364.3) also has a conserved TK
domain (aa 970–1237; 95.5% identical to human), but a much
shorter N-terminus (aa 1–883) with only 53.3% identity. When Alk
sequences from 17 vertebrate species and Drosophila melanogaster
were compared, the TK domain was the most conserved part
among all Alk’s. In contrast, the Alk N-terminus showed much
more variation, consistent with the idea that the N-terminus of Alk
has undergone extensive divergence during vertebrate evolution.
In mammals, ALK and LTK can be clearly distinguished by their
extracellular domains, with respect to its length (1030 aa vs. 424
aa) and the presence or absence of MAM domains, respectively
[48,49]. Phylogenetic analyses suggested that the MAM domain is
a feature of a common Alk/Ltk ancestor, and has been retained in
Ltk in zebrafish and chicken but not mammals [17]. It is likely that
Ltk and Alk evolved their N-termini differently in mammals and in
teleosts. As a consequence, mammalian Ltk lost some of the fish
specific Ltk functions, such as for iridophore development [17].
Expression of alk in the central nervous system
In mouse, Alk is prominently expressed in the diencephalon, the
neuroepithelium surrounding the fourth ventricle, the ventricular
and subventricular zone of the cortex, the midbrain, and the
medulla oblongata from day 10.5 to day 16.5 [14]. Similar to
mouse, alk is expressed in most of the central nervous system
(CNS) in zebrafish. However, in mouse and chicken, Alk
expression is also detected in the spinal cord [12,14]. In contrast,
zebrafish alk could not be detected in the spinal cord under the
experimental conditions used, especially after 24 hpf (Fig. 1C,H).
This could possibly reflect species-specific differences in Alk
expression among different vertebrates. In mouse, rat, and
chicken, Alk is also expressed in the peripheral nervous system
(PNS) including the trigeminal ganglia, facial ganglia, vestibuloco-
chlear ganglia, inferior ganglia of the vagus nerve, as well as dorsal
root ganglia and sympathetic ganglia [12,13,14]. In our study, we
could not detect expression of zebrafish alk in the PNS. On the
other hand, the similar spatiotemporal expression patterns of Alk in
the early CNS in mouse [14], chicken [12], and zebrafish (this
Figure 6. Inhibition of Alk activity by CEP-26939 phenocopies
alk morphant defects. (A,C,E,G,I) Embryos at 60 hpf treated with
1% DMSO from 24 hpf were used as negative controls. (B,D,F,H,J)
60 hpf embryos treated with 40 mM CEP-26939 from 24 hpf. (A,B)
Inhibitor treated embryos showed more TUNEL-positive apoptotic cells
in mid- and hindbrain (B) when compared to DMSO treated embryos
(A). (C,D) No significant change was observed for her6 expression in
inhibitor treated embryos. (E,F) neurog1 was only slightly reduced in
inhibitor treated (F) compared to DMSO treated embryos (E). (G,H,I,J)
Both neurod4 and ascl1b expression domains in mid- and hindbrain
were almost completely absent in inhibitor treated embryos (H,J). All
images show dorsal views with the focal plane on mid- and hindbrain,
with anterior to the left. Numbers in each image indicate individuals
similar as that shown as representatives and total numbers of embryos
investigated. Scale bars: 100 mm.
doi:10.1371/journal.pone.0063757.g006
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study) suggest that the activity and function of the highly related
Alk tyrosine kinase domain is conserved during CNS neurogenesis.
In vivo activity of over-expressed, non-mutated Alk
Receptor protein tyrosine kinases (RTKs) can undergo sponta-
neous dimerization, transphosphorylation of monomers, and
activation. This process is promoted and stabilized by the presence
of RTK ligands [50,51]. In our alk overexpression experiments,
Alk proteins could have spontaneously formed active dimers,
resulting in RTK activation. Such autophosphorylation of ALK in
absence of any ligand was also reported in cell culture [52]. The
observed activation of MEK/ERK pathway confirmed that the
transgenic Alk proteins are expressed and enzymatically active.
Interestingly, we observed a high degree of mosaicism of MEK/
ERK activation although the Alk transgene was ubiquitously
expressed. While the exact reason for this remains unclear, it
suggests a dynamic regulation of intracellular signaling when Alk is
activated in this in vivo context. Overexpression of alk in these
transgenic lines resulted in enhanced cell proliferation with
increased numbers of cells in M-phase and up-regulation of ccnd1
expression. Furthermore, aberrant neurogenesis patterns were
observed with ectopic localization of differentiated neurons. We
therefore propose that ectopic activation of Alk leads to excess
MAPK activity resulting in increased proliferation of neuronal
progenitors, randomized cell cycle exit and differentiation, and
consequently mis-positioning of differentiating neurons. Trigger-
ing alk overexpression at a later stage (24 hpf) also enhanced
proliferation but strikingly to a much lesser extent and in a
spatially more restricted fashion (data not shown) when compared
to overexpression at 10.5 hpf (Fig. 2). Recent studies suggested
that overexpression of mutated ALK works cooperatively with
MYCN overexpression to promote the severity of induced
neuroblastoma [53,54]. Interestingly, zebrafish nmyc1, the ortholog
of human MYCN, is expressed ubiquitously at high levels in the
CNS before 24 hpf, but becomes restricted thereafter [55]. This
could explain why proliferative effects of overexpressed Alk were
higher at earlier embryonic stages.
Alk is required for differentiation and survival in the CNS
but not proliferation
We show that an alk knock-down does not affect cell
proliferation in the hindbrain at 24 hpf. Interestingly, decreased
cell proliferation was reported in in vitro cultured neuroblastoma
cell lines where ALK has been depleted by siRNA [8,11]. Also, a
recent report using cultured chicken sympathetic neurons derived
from PNS sympathetic ganglia showed that the knock-down of
endogenous chicken Alk results in reduced proliferation [15]. This
suggests possible differences of Alk function in different tissues and
cell types. Alternatively, it could also reflect differences between in
vivo and in vitro cell culture conditions suggesting more complicated
Figure 7. Knock-down of alk reduces the number of differentiated hindbrain neurons. (A–D) Confocal sections of 31 hpf embryos at r5
level immunostained with the pan-neuronal marker HuC/D (green) and co-stained with bodipy-Texas Red (TR, red). The HuC/D channel (green) is
separately shown in (A9–D9). Arrowheads point to emerging neurons in the ear, serving as landmark to indicate that all sections were at the same
position. In both alk ATG-MO (B,B9) or alk Spl-MO (C,C9) injected embryos, the areas of postmitotic neurons were clearly smaller than in WT (A,A9) or
alk ATGmismatch-MO injected embryos (D,D9). The proliferative ventricular and subventricular zones were normal in size. (E) Y-axis indicates
numbers of HuC/D expressing cells on sections. Both alk ATG-MO and alk Spl-MO groups were significantly different from WT (***p,0.001), whereas
the change in alk ATGmismatch-MO group was not significant (p = 0.088). Mean 6 SEM, N= 12 in WT and ATG-MO, N= 14 in Spl-MO and
ATGmismatch-MO. Unpaired two tailed t-test. Scale bars: 50 mm.
doi:10.1371/journal.pone.0063757.g007
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scenarios that underlay Alk mediated cell cycle control, such as
impact of the microenvironment or functional redundancy with
other kinases that cannot be fully mimicked in cell culture settings.
In alk deficient embryos, generated by MO-mediated ALK
depletion or pharmacological inhibition of its enzymatic activity, a
universal increase in neural cell apoptosis and reduction in
expression of selected proneural genes was observed. Since
progenitor marker expression was unchanged and cell prolifera-
tion was not affected in hindbrain, this indicates that progenitor
cells are not impaired by alk deficiency and that the observed
apoptosis does not originate from neural progenitors. On the other
hand, reduced proneural gene expression in differentiating
neuronal precursors suggests defects in differentiation eventually
leading to cell death. There are several possibilities how alk
deficiency could affect cell survival. First, differentiating neural
cells could undergo apoptosis because Alk is a survival factor and
functions as a repressor of cell death. Thus, reduced proneural
gene expression could simply reflect a reduction in the numbers of
differentiating cells. Alternatively, Alk could be a specification
factor, which is required to promote proneural gene expression. In
morphants, cells that have exited the progenitor state would
therefore fail to differentiate and consequently commence
apoptosis. It remains unclear at present whether Alk induced
apoptosis is the cause or consequence of impaired neurogenesis.
However, our study showed that the extent of apoptosis in
embryos deficient for Alk is relatively mild compared to the
extensive changes in neurogenic gene expression. This observation
favours a scenario where Alk deficiency leads to impaired
neurogenesis, which subsequently results in apoptosis.
Unfortunately, Alk knock-out animals other than the embryos
presented here are lacking in order to address which of the
scenarios explains increased apoptosis after alk knock-down.
Interestingly and in agreement with a role as specification factor,
the Alk co-ortholog Ltk is involved in cell fate specification of
multipotent precursors in the iridophore lineage (Lopes et al.,
2008). On the other hand, siRNA-based approaches recently
reported increased apoptosis upon Alk knock-down in neuroblas-
toma cell lines [56] supporting the idea of Alk as a survival factor.
It is well established that proneural genes are required for cell
survival during neuronal differentiation [57,58,59]. Based on this
and our own observations, a combination of both scenarios
therefore seems likely. We propose that Alk is required for the
survival of neural precursors that have exited the progenitor state
and are about to enter different neural differentiation fates.
Supporting Information
Figure S1 Sense controls and expression of zebrafish
alk at 72 hpf. (A–D) Negative controls at 24 hpf using a sense
probe, corresponding to Fig. 1D–G, respectively. (E–G) Negative
controls at 48 hpf using a sense probe, corresponding to Fig. 1I–K,
respectively. (H) Lateral view of embryo at 72 hpf with dorsal up
and anterior to the left. (I) Dorsal high magnification views of
head region at 72 hpf. (J) Negative sense probe control of (I). Scale
bars: A–G, 100 mm; H–J, 200 mm.
(JPG)
Figure S2 Heat-shock inducible transgenic zebrafish
lines. (A,B) Diagrams illustrating transgenic cassettes for control
line (A) and alk overexpression lines (B). The construct reported by
Bajoghli et al. contains eight heat shock element repeats (HSE)
with bidirectional promoter activity. This construct was engi-
neered in such a way that alk and cfp were put on each side (B), or
just cfp in the control line (A). (C–E) 24hpf embryos from the
control line (HSE:cfp, C), alk overexpression line 1 (alk:HSE:cfp1,
D), and independent alk overexpression line 2 (alk:HSE:cfp2, E). All
embryos received a 1.5 hour long heat shock at 39.5uC and at
10.5 hpf. Bright field images on top and images of the same
embryos in CFP channel below. Inserts show representative
transgene positive embryos in each line. Arrows point to
transgenic negative siblings in each line. They are morphologically
normal and not visible in the CFP channel.
(JPG)
Figure S3 In situ hybridization to detect alk overex-
pression in alk:HSE:cfp transgenic embryos. A heat shock
was performed at 24 hpf. All in situ hybridizations were done using
an alk antisense RNA probe, at 1 hour post heat shock (hph) (A),
6 hph (B), 22 hph (C), and shortly after a second HS performed
at 48 hpf (D). Inserts show representative transgenic positive
embryos. As soon as 1 hour after heat shock, high levels of
exogenous alk RNA could be detected in the entire embryo.
Reduced staining at 6 hours after HS indicated RNA degradation.
Staining almost completely disappeared at 22 hours after HS. A
second HS re-activated transcription of overexpressed alk. Arrows
points to transgene negative siblings where no exogenous alk was
detected. Endogenous alk expression was not detected because of
short staining time.
(JPG)
Figure S4 Proliferation and differentiation in the
alk:HSE:cfp2 line. (A,B) Confocal sections of 24hpf embryos
of the alk:HSE:cfp2 line. Sib (A) and Tg+ (B) had different neural
tube shapes. Dividing cells (pH 3, green) and neurons (HuC/D,
red) in Tg+ embryos (B) were both mispositioned (arrowhead),
identical to defects observed in the alk:HSE:cfp1 line (Fig. 2).
Asterisk labels 4th ventricle. (C,C9,D,D9) Ectopic pERK (arrows)
in Tg+ (D,D9) of the alk:HSE:cfp2 line compared to Sib (C,C9),
identical to defects observed in alk:HSE:cfp1 (Fig. 3). pERK,
phosphorylated-ERK1/2. Sib, transgene negative siblings. Tg+,
transgenic embryos. Scale bars: 50 mm.
(JPG)
Figure S5 alk MO efficiency test experiments. (A) A
schematic diagram showing arrangement of the first four alk exon-
intron boundaries and MO binding sites. Numbers show exon/
intron sizes in basepairs. (B) A construct containing egfp inserted in
frame with the alk ATG site was generated to test the binding
efficiency of ATG-MO. (C–F) Injection of this mRNA in
combination with MOs resulted in different EGFP translation
levels. Embryos at 8 hpf, with bright field images on top and
fluorescent images below. Injection of the mRNA resulted in
EGFP signal (D). Co-injection with alk ATG-MO blocked its
translation (E). alk ATGmismatch-MO did not block its translation
(F). Embryos labeled with asterisks in (C) and (E) were taken from
the group shown in (D), indicating sufficient fluorescent excitation.
(G) A diagram showing aberrant splice products with retention of
intron 3, when alk pre-mRNA splicing is blocked by splicing MOs.
(H) RT-PCRs were used to test splicing MO efficiency by primers
indicated in (A). In Spl-MO injected 24 hpf embryos, the PCR
product size was increased by approximately 300 bp (2nd lane)
when compared to uninjected wild-type (1st lane), indicating
retention of intron 3. -RT controls (3rd and 4th lanes, without
reverse transcriptase in cDNA synthesis) excluded contamination
by genomic DNA. gapdh was used as loading control.
(JPG)
Figure S6 Increased apoptosis in alk morphants. TU-
NEL staining of embryos at 22 hpf. Images show lateral views on
top with anterior to the left, and dorsal views of head region below
with anterior to the top. WT (A) or Std-MO injected (B) embryos
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had only few scattered TUNEL positive cells. In alk ATG-MO (C)
or Spl-MO injected embryos (F), TUNEL positive cells increased
in number, while ATGmismatch-MO injected (E) looked normal.
Co-injections with p53-MO (D,G) failed to attenuate the
apoptosis defect indicating specificity of the effect. Scale bars:
100 mm.
(JPG)
Figure S7 An alk ATG-MO leads to reduced proneural
gene expression. (A,C,E,G,I,K) Embryos injected with alk
ATGmismatch-MO showed no difference when compared to WT
in Fig. 5. (B,D,F,H,J,L) alk ATG-MO injected embryos show the
same phenotype as alk Spl-MO injected embryos (Fig. 5). Embryos
showed no change in her6, neurog1 and gfap expression, but reduced
expression of neurod4, ascl1b and dla identical to alk Spl-MO
injected embryos shownin Fig. 5. Images show dorsal views of
head regions with anterior to the left. Scale bars: 50 mm.
(JPG)
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